Skip to main content
  1. Home
  2. Emerging Tech
  3. Legacy Archives

Russia bans Bitcoin, labels it a “money substitute”

Add as a preferred source on Google

You have to feel sorry for Bitcoin users trying to keep up with their favorite cryptocurrency, as every week its fortunes seem to swing up and down. In the past 24 hours, Russia has officially banned the use of Bitcoin in a ruling that labels it a “money substitute” — essentially, if you have a Bitcoin wallet on your computer in Russia, you’re breaking the law.

The official statement (fire up your Google Translate plugins) notes that virtual currencies such as Bitcoin have been associated with criminal money laundering, and this is part of the reason why the authorities have clamped down on their use. The announcement also makes reference to Bitcoin’s “lack of security” and fluctuating value.

Recommended Videos

This doesn’t mean that Bitcoin will disappear overnight from Russia: as TechCrunch points out, it’s likely to be only companies using Bitcoin and located in the country who will be targeted. Despite Bitcoin’s founding principle of being an unregulated alternative currency, its growing prominence makes that ideal harder to maintain.

In other Bitcoin news,  Japan’s Mt. Gox exchange has been forced to shut down for the weekend as it struggles with issues affecting customer payments. Once the go-to exchange for the virtual currency, Mt. Gox has struggled with government seizures and technical glitches in recent months.

In a press release, the exchange says: “All Bitcoin withdrawal requests will be on pause, and the withdrawals in the system will be returned to your MtGox wallet and can be reinitiated once the issue is resolved. The trading platform will perform as usual for the needs of our customers.” An update is expected on Monday.

Another tumultuous week for Bitcoiners then, but this is to be expected when you sign up for a fledging cryptocurrency that the authorities can’t make their minds up on. At least Apple’s position is clear: all Bitcoin apps have now been removed from the App Store, much to the chagrin of users.

David Nield
Former Contributor
Dave is a freelance journalist from Manchester in the north-west of England. He's been writing about technology since the…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more